Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 595

1.

Who emphasizes positivity? An exploration of emotion values in people of Latino, Asian, and European heritage living in the United States.

Senft N, Campos B, Shiota MN, Chentsova-Dutton YE.

Emotion. 2020 Mar 19. doi: 10.1037/emo0000737. [Epub ahead of print]

PMID:
32191097
2.

Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer.

Shiota M, Fujimoto N, Yamamoto Y, Takeuchi A, Tatsugami K, Uchiumi T, Matsuyama H, Eto M.

Cancer Immunol Immunother. 2020 Mar 2. doi: 10.1007/s00262-020-02533-8. [Epub ahead of print]

PMID:
32123936
3.

Family history in primary hormone therapy for prostate cancer: Analysis from a community-based multi-institutional Japan-wide database.

Shiota M, Onozawa M, Hinotsu S, Eto M, Naito S, Akaza H; Japan Study Group of Prostate Cancer (J-CaP).

Int J Urol. 2020 Apr;27(4):313-318. doi: 10.1111/iju.14184. Epub 2020 Feb 10.

PMID:
32037622
4.

Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancer.

Hirata Y, Shiota M, Kobayashi T, Kashiwagi E, Takeuchi A, Inokuchi J, Tatsugami K, Eto M.

Prostate Int. 2019 Dec;7(4):166-170. doi: 10.1016/j.prnil.2019.10.003. Epub 2019 Nov 14.

5.

Rectal cancer with extensive distal intramural spread treated by abdominoperineal resection.

Sato H, Shiota M, Okabe A, Tsukamoto T, Honda K, Morise Z, Uyama I.

Int Cancer Conf J. 2019 Aug 7;9(1):9-13. doi: 10.1007/s13691-019-00385-3. eCollection 2020 Jan.

PMID:
31950010
6.

Generation of Rat Monoclonal Antibodies Specific for Human Stromal Cell-Derived Factor-2.

Tanaka M, Shiota M, Koyama M, Nakayama J, Yashiro M, Semba K, Goda N.

Monoclon Antib Immunodiagn Immunother. 2020 Feb;39(1):23-26. doi: 10.1089/mab.2019.0043. Epub 2020 Jan 9.

7.

Prognostic significance of lactate dehydrogenase in cabazitaxel chemotherapy for castration-resistant prostate cancer: a multi-institutional study.

Shiota M, Nakamura M, Yokomizo A, Tomoda T, Sakamoto N, Seki N, Hasegawa S, Yunoki T, Harano M, Kuroiwa K, Eto M.

Anticancer Drugs. 2020 Mar;31(3):298-303. doi: 10.1097/CAD.0000000000000884.

PMID:
31913197
8.

Prognostic Impact of Prior Androgen Receptor Axis-targeting Agents in Cabazitaxel Chemotherapy After Docetaxel.

Shiota M, Nakamura M, Yokomizo A, Tomoda T, Sakamoto N, Seki N, Hasegawa S, Yunoki T, Harano M, Kuroiwa K, Eto M.

Anticancer Res. 2020 Jan;40(1):335-339. doi: 10.21873/anticanres.13957.

PMID:
31892584
9.

Effects of orally active hypoxia inducible factor alpha prolyl hydroxylase inhibitor, FG4592 on renal fibrogenic potential in mouse unilateral ureteral obstruction model.

Kabei K, Tateishi Y, Shiota M, Osada-Oka M, Nishide S, Uchida J, Nakatani T, Matsunaga S, Yamaguchi T, Tomita S, Miura K.

J Pharmacol Sci. 2020 Mar;142(3):93-100. doi: 10.1016/j.jphs.2019.12.002. Epub 2019 Dec 6.

10.

Assessing Chemical-Induced Liver Injury In Vivo From In Vitro Gene Expression Data in the Rat: The Case of Thioacetamide Toxicity.

Schyman P, Printz RL, Estes SK, O'Brien TP, Shiota M, Wallqvist A.

Front Genet. 2019 Nov 26;10:1233. doi: 10.3389/fgene.2019.01233. eCollection 2019.

12.

Genome-Scale Model-Based Identification of Metabolite Indicators for Early Detection of Kidney Toxicity.

Pannala VR, Vinnakota KC, Estes SK, Trenary I, OˈBrien TP, Printz RL, Papin JA, Reifman J, Oyama T, Shiota M, Young JD, Wallqvist A.

Toxicol Sci. 2020 Feb 1;173(2):293-312. doi: 10.1093/toxsci/kfz228.

PMID:
31722432
13.

The Autophagy-Related Protein GABARAP Is Induced during Overwintering in the Bean Bug (Hemiptera: Alydidae).

Tachibana SI, Matsuzaki S, Tanaka M, Shiota M, Motooka D, Nakamura S, Goto SG.

J Econ Entomol. 2020 Feb 8;113(1):427-434. doi: 10.1093/jee/toz287.

PMID:
31693096
14.

Controlling the Phenotype of Tumor-Infiltrating Macrophages via the PHD-HIF Axis Inhibits Tumor Growth in a Mouse Model.

Nishide S, Matsunaga S, Shiota M, Yamaguchi T, Kitajima S, Maekawa Y, Takeda N, Tomura M, Uchida J, Miura K, Nakatani T, Tomita S.

iScience. 2019 Nov 22;21:205. doi: 10.1016/j.isci.2019.10.031. Epub 2019 Oct 28. No abstract available.

15.
16.

Metabolomics analyses of the combined effects of lactic acid bacteria and Penicillium camemberti on the generation of volatile compounds in model mold-surface-ripened cheeses.

Suzuki-Iwashima A, Matsuura H, Iwasawa A, Shiota M.

J Biosci Bioeng. 2020 Mar;129(3):333-347. doi: 10.1016/j.jbiosc.2019.09.005. Epub 2019 Oct 11.

PMID:
31611057
17.

Controlling the Phenotype of Tumor-Infiltrating Macrophages via the PHD-HIF Axis Inhibits Tumor Growth in a Mouse Model.

Nishide S, Matsunaga S, Shiota M, Yamaguchi T, Kitajima S, Maekawa Y, Takeda N, Tomura M, Uchida J, Miura K, Nakatani T, Tomita S.

iScience. 2019 Sep 27;19:940-954. doi: 10.1016/j.isci.2019.08.033. Epub 2019 Aug 28. Erratum in: iScience. 2019 Nov 22;21:205.

18.

X-ray structure of the direct electron transfer-type FAD glucose dehydrogenase catalytic subunit complexed with a hitchhiker protein.

Yoshida H, Kojima K, Shiota M, Yoshimatsu K, Yamazaki T, Ferri S, Tsugawa W, Kamitori S, Sode K.

Acta Crystallogr D Struct Biol. 2019 Sep 1;75(Pt 9):841-851. doi: 10.1107/S2059798319010878. Epub 2019 Aug 28.

19.

Emotion recognition in objects in patients with neurological disease.

Shiota MN, Simpson ML, Kirsch HE, Levenson RW.

Neuropsychology. 2019 Nov;33(8):1163-1173. doi: 10.1037/neu0000587. Epub 2019 Sep 2.

PMID:
31478721
20.

Therapeutic Silencing of Centromere Protein X Ameliorates Hyperglycemia in Zebrafish and Mouse Models of Type 2 Diabetes Mellitus.

Zang L, Shimada Y, Nakayama H, Chen W, Okamoto A, Koide H, Oku N, Dewa T, Shiota M, Nishimura N.

Front Genet. 2019 Jul 29;10:693. doi: 10.3389/fgene.2019.00693. eCollection 2019.

21.

TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.

Sekino Y, Han X, Kawaguchi T, Babasaki T, Goto K, Inoue S, Hayashi T, Teishima J, Shiota M, Yasui W, Matsubara A.

Int J Mol Sci. 2019 Aug 13;20(16). pii: E3936. doi: 10.3390/ijms20163936.

22.

Therapeutic Outcome of >10 Cycles of Cabazitaxel for Castration-resistant Prostate Cancer: A Multi-institutional Study.

Shiota M, Nakamura M, Yokomizo A, Tomoda T, Sakamoto N, Seki N, Hasegawa S, Yunoki T, Harano M, Kuroiwa K, Eto M.

Anticancer Res. 2019 Aug;39(8):4411-4414. doi: 10.21873/anticanres.13612.

PMID:
31366538
23.

Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer.

Akitake M, Yamaguchi A, Shiota M, Imada K, Tatsugami K, Yokomizo A, Naito S, Eto M.

Anticancer Res. 2019 Aug;39(8):4325-4328. doi: 10.21873/anticanres.13598.

PMID:
31366524
24.

Osteoconductive potential of a hydroxyapatite fiber material with magnesium: In vitro and in vivo studies.

Kozuma W, Kon K, Kawakami S, Bobothike A, Iijima H, Shiota M, Kasugai S.

Dent Mater J. 2019 Oct 2;38(5):771-778. doi: 10.4012/dmj.2018-333. Epub 2019 Jun 29.

25.

Psoas muscle volume is correlated with sexual activity and erectile dysfunction among patients with localised prostate cancer.

Kashiwagi E, Imada K, Monji K, Takeuchi A, Shiota M, Inokuchi J, Tatsugami K, Eto M.

Andrologia. 2019 Oct;51(9):e13354. doi: 10.1111/and.13354. Epub 2019 Jun 23.

PMID:
31230398
26.

The Role of Nuclear Receptors in Prostate Cancer.

Shiota M, Fujimoto N, Kashiwagi E, Eto M.

Cells. 2019 Jun 17;8(6). pii: E602. doi: 10.3390/cells8060602. Review.

27.

Prognostic significance of antihypertensive agents in men with castration-resistant prostate cancer.

Shiota M, Kobayashi T, Kashiwagi E, Takeuchi A, Inokuchi J, Tatsugami K, Eto M.

Urol Oncol. 2019 Nov;37(11):813.e21-813.e26. doi: 10.1016/j.urolonc.2019.04.020. Epub 2019 Jun 12.

PMID:
31202731
28.

Serum Prognostic Factors of Androgen-deprivation Therapy Among Japanese Men With De Novo Metastatic Prostate Cancer.

Kobayashi T, Namitome R, Hirata YU, Shiota M, Imada K, Kashiwagi E, Takeuchi A, Inokuchi J, Tatsugami K, Eto M.

Anticancer Res. 2019 Jun;39(6):3191-3195. doi: 10.21873/anticanres.13457.

PMID:
31177166
29.

Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study.

Shiota M, Nakamura M, Yokomizo A, Tomoda T, Sakamoto N, Seki N, Hasegawa S, Yunoki T, Harano M, Kuroiwa K, Eto M.

Cancer Chemother Pharmacol. 2019 Sep;84(3):561-566. doi: 10.1007/s00280-019-03874-7. Epub 2019 May 21.

PMID:
31115605
30.

Primary Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer in Asia: Unique or Not?

Shiota M.

J Natl Compr Canc Netw. 2019 May 1;17(5):523-524. doi: 10.6004/jnccn.2019.7302. No abstract available.

PMID:
31085760
31.

Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapy.

Shiota M, Ushijima M, Imada K, Kashiwagi E, Takeuchi A, Inokuchi J, Tatsugami K, Kajioka S, Eto M.

Prostate. 2019 Jul;79(10):1147-1155. doi: 10.1002/pros.23828. Epub 2019 May 11.

PMID:
31077419
32.

Reconsideration on Clinical Benefit of Pelvic Lymph Node Dissection during Radical Prostatectomy for Clinically Localized Prostate Cancer.

Fujimoto N, Shiota M, Tomisaki I, Minato A, Yahara K.

Urol Int. 2019;103(2):125-136. doi: 10.1159/000497280. Epub 2019 Apr 30. Review.

33.

Genetic Polymorphism in Sex Hormone-binding Globulin With a Prognosis of Androgen Deprivation Therapy in Metastatic Prostate Cancer Among Japanese Men.

Shiota M, Fujimoto N, Tsukahara S, Ushijima M, Takeuchi A, Kashiwagi E, Inokuchi J, Tatsugami K, Uchiumi T, Eto M.

Clin Genitourin Cancer. 2019 Jun;17(3):e387-e393. doi: 10.1016/j.clgc.2019.03.021. Epub 2019 Apr 6.

PMID:
31036465
34.

Mechanistic identification of biofluid metabolite changes as markers of acetaminophen-induced liver toxicity in rats.

Pannala VR, Vinnakota KC, Rawls KD, Estes SK, O'Brien TP, Printz RL, Papin JA, Reifman J, Shiota M, Young JD, Wallqvist A.

Toxicol Appl Pharmacol. 2019 Jun 1;372:19-32. doi: 10.1016/j.taap.2019.04.001. Epub 2019 Apr 8.

PMID:
30974156
35.

A Study on the Incidence and Comorbidities of Autism Spectrum Disorders Accompanied by Intellectual Disabilities in Yonago City, Japan.

Nomura K, Yamaguchi M, Yokoyama M, Shiota M, Ohno K, Maegaki Y.

Yonago Acta Med. 2019 Mar 28;62(1):8-13. eCollection 2019 Mar.

36.

Network Modeling of Liver Metabolism to Predict Plasma Metabolite Changes During Short-Term Fasting in the Laboratory Rat.

Vinnakota KC, Pannala VR, Wall ML, Rahim M, Estes SK, Trenary I, O'Brien TP, Printz RL, Reifman J, Shiota M, Young JD, Wallqvist A.

Front Physiol. 2019 Mar 1;10:161. doi: 10.3389/fphys.2019.00161. eCollection 2019.

37.

Ethnic variation in gratitude and well-being.

Corona K, Senft N, Campos B, Chen C, Shiota M, Chentsova-Dutton YE.

Emotion. 2020 Apr;20(3):518-524. doi: 10.1037/emo0000582. Epub 2019 Mar 14.

PMID:
30869943
38.

The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men.

Shiota M, Fujimoto N, Tsukahara S, Ushijima M, Takeuchi A, Kashiwagi E, Inokuchi J, Tatsugami K, Uchiumi T, Eto M.

Cancer Chemother Pharmacol. 2019 May;83(5):933-938. doi: 10.1007/s00280-019-03811-8. Epub 2019 Mar 13.

PMID:
30868236
39.

Efficacy and safety of cabazitaxel for castration-resistant prostate cancer in patients with > 10 cycles of docetaxel chemotherapy: a multi-institutional study.

Shiota M, Nakamura M, Yokomizo A, Tomoda T, Sakamoto N, Seki N, Hasegawa S, Yunoki T, Harano M, Kuroiwa K, Eto M.

Med Oncol. 2019 Feb 28;36(4):32. doi: 10.1007/s12032-019-1257-1.

PMID:
30815799
40.

The Effect of Dissociated Soft Tissue on Osteogenesis: A Preliminary In Vitro Study.

Kawakami S, Shiota M, Kon K, Shimogishi M, Kasugai S.

Int J Oral Maxillofac Implants. 2019 May/June;34(3):651–657. doi: 10.11607/jomi.7021. Epub 2019 Feb 26.

PMID:
30807626
41.

Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone.

Shiota M, Narita S, Akamatsu S, Fujimoto N, Sumiyoshi T, Fujiwara M, Uchiumi T, Habuchi T, Ogawa O, Eto M.

JAMA Netw Open. 2019 Feb 1;2(2):e190115. doi: 10.1001/jamanetworkopen.2019.0115.

42.

Primary non-gestational uterine choriocarcinoma mimicking leiomyoma.

Sano R, Moriya T, Suzuki S, Saito W, Shimoya K, Shiota M.

Pathol Int. 2019 Mar;69(3):160-164. doi: 10.1111/pin.12763. Epub 2019 Feb 18. Review.

PMID:
30775828
43.

KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer.

Sekino Y, Oue N, Koike Y, Shigematsu Y, Sakamoto N, Sentani K, Teishima J, Shiota M, Matsubara A, Yasui W.

J Clin Med. 2019 Feb 9;8(2). pii: E225. doi: 10.3390/jcm8020225.

44.

Responding to the emotions of others: Age differences in facial expressions and age-specific associations with relational connectedness.

Lwi SJ, Haase CM, Shiota MN, Newton SL, Levenson RW.

Emotion. 2019 Dec;19(8):1437-1449. doi: 10.1037/emo0000534. Epub 2019 Feb 7.

PMID:
30730167
45.

[Outcomes of Anal Squamous Cell Carcinoma Treated with Chemoradiotherapy].

Sato H, Koide Y, Shiota M, Mizuno M, Morise Z, Uyama I.

Gan To Kagaku Ryoho. 2018 Dec;45(13):1907-1909. Japanese.

PMID:
30692394
46.

A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4.

Yamaguchi T, Watanabe A, Tanaka M, Shiota M, Osada-Oka M, Sano S, Yoshiyama M, Miura K, Kitajima S, Matsunaga S, Tomita S, Iwao H, Izumi Y.

J Pharmacol Sci. 2019 Feb;139(2):112-119. doi: 10.1016/j.jphs.2018.12.004. Epub 2018 Dec 18.

47.

Mirabegron induces relaxant effects via cAMP signaling-dependent and -independent pathways in detrusor smooth muscle.

Maki T, Kajioka S, Itsumi M, Kareman E, Lee K, Shiota M, Eto M.

Low Urin Tract Symptoms. 2019 Apr;11(2):O209-O217. doi: 10.1111/luts.12247. Epub 2019 Jan 10.

PMID:
30632283
48.

Prognostic Impact of Genetic Polymorphism in Mineralocorticoid Receptor and Comorbidity With Hypertension in Androgen-Deprivation Therapy.

Shiota M, Fujimoto N, Imada K, Kashiwagi E, Takeuchi A, Inokuchi J, Tatsugami K, Kajioka S, Uchiumi T, Eto M.

Front Oncol. 2018 Dec 18;8:635. doi: 10.3389/fonc.2018.00635. eCollection 2018.

49.

Glutamate-oxaloacetate transaminase activity promotes palmitate lipotoxicity in rat hepatocytes by enhancing anaplerosis and citric acid cycle flux.

Egnatchik RA, Leamy AK, Sacco SA, Cheah YE, Shiota M, Young JD.

J Biol Chem. 2019 Mar 1;294(9):3081-3090. doi: 10.1074/jbc.RA118.004869. Epub 2018 Dec 18.

50.

Peripheral Mechanisms Mediating the Sustained Antidiabetic Action of FGF1 in the Brain.

Scarlett JM, Muta K, Brown JM, Rojas JM, Matsen ME, Acharya NK, Secher A, Ingvorsen C, Jorgensen R, Høeg-Jensen T, Stefanovski D, Bergman RN, Piccinini F, Kaiyala KJ, Shiota M, Morton GJ, Schwartz MW.

Diabetes. 2019 Mar;68(3):654-664. doi: 10.2337/db18-0498. Epub 2018 Dec 6.

Supplemental Content

Loading ...
Support Center